Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

431.64 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
TMO Q1 Earnings Call: Navigating Tariffs and Macro Uncertainty While Investing in Innovation
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15 per... 
Via StockStory
Topics Economy World Trade
Exposures Supply Chain Tariff
Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit and lower operating income. 
Via Benzinga
Topics World Trade
Exposures Tariff
Thermo Fisher Reports Strong Q1 Earnings But Revises Full-Year Guidance In Light Of Trump Tariffs: Retail’s Pessimistic
The company now expects 2025 revenue to be in the range of $43.3 billion to $44.2 billion and adjusted EPS to be in the range of $21.76 to $22.84, compared with its previous forecast of $23.10 to... 
Via Stocktwits
Topics Earnings Government World Trade
Exposures Financial Political Tariff
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth. 
Via Benzinga
Earnings Scheduled For April 23, 2025
Via Benzinga
Earnings Preview For Thermo Fisher Scientific
Via Benzinga
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
Exposures Political
Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q1
Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $10.36 billion. Its non-GAAP profit of $5.15... 
Via StockStory
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect
Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect. 
Via StockStory
$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Via Benzinga
S&P 500 Index Stocks To Watch: Google, Tesla, IBM, Intel, AT&T, Boeing, Chipotle
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Assessing Thermo Fisher Scientific: Insights From 9 Financial Analysts
Via Benzinga
Thermo Fisher Scientific Stock Up 1.3% After Key Signal
A significant trading signal occurred for shares of Thermo Fisher Scientific at $444.92, after which TMO rose up to 1.3%. 
Via Benzinga
A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack
Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
Exposures Supply Chain
Why Quality Investors Should Delve into THERMO FISHER SCIENTIFIC INC (NYSE:TMO) for Investment Opportunities.
A fundamental analysis of (NYSE:TMO): Is THERMO FISHER SCIENTIFIC INC (NYSE:TMO) suited for quality investing? 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy
Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS. 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Is the Market Bullish or Bearish on Thermo Fisher Scientific?
Via Benzinga
3 Reasons to Sell TMO and 1 Stock to Buy Instead
Over the last six months, Thermo Fisher shares have sunk to $508.90, producing a disappointing 17.1% loss - worse than the S&P 500’s 1.2% drop. This might have investors contemplating their next move. 
Via StockStory
Topics Stocks
Exposures US Equities
Market Whales and Their Recent Bets on TMO Options
Via Benzinga
On Sale Now: 20 Blue Chip Stocks to Buy
These 20 blue chip companies are the largest traded on U.S. exchanges. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Dividend Stocks That Recently Raised Payouts More Than 10%
Via The Motley Fool
Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom'
David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs (NYSE: GS), has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends. 
Via Benzinga
Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSE:RVTY) and the best and worst... 
Via StockStory
Topics Economy
Exposures Supply Chain
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.